Evidence-based appraisal of antireflux fundoplication M Catarci, P Gentileschi, C Papi, A Carrara, R Marrese, AL Gaspari, ... Annals of surgery 239 (3), 325-337, 2004 | 440 | 2004 |
Timing of cholecystectomy for acute calculous cholecystitis: a meta-analysis C Papi, M Catarci, L D'ambrosio, L Gili, M Koch, GB Grassi, L Capurso Official journal of the American College of Gastroenterology| ACG 99 (1 …, 2004 | 406 | 2004 |
Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ... Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011 | 377 | 2011 |
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study G Corrao, A Tragnone, R Caprilli, G Trallori, C Papi, A Andreoi, ... International journal of epidemiology 27 (3), 397-404, 1998 | 252 | 1998 |
Meta‐analysis: long‐term therapy with rifaximin in the management of uncomplicated diverticular disease M Bianchi, V Festa, A Moretti, A Ciaco, M Mangone, V Tornatore, A Dezi, ... Alimentary pharmacology & therapeutics 33 (8), 902-910, 2011 | 237 | 2011 |
Colectomy rate in acute severe ulcerative colitis in the infliximab era A Aratari, C Papi, V Clemente, A Moretti, R Luchetti, M Koch, L Capurso, ... Digestive and Liver Disease 40 (10), 821-826, 2008 | 228 | 2008 |
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial C Papi, A Ciaco, M Koch, L Capurso Alimentary pharmacology & therapeutics 9 (1), 33-39, 1995 | 205 | 1995 |
Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study L Biancone, A Orlando, A Kohn, E Colombo, R Sostegni, E Angelucci, ... Gut 55 (2), 228-233, 2006 | 180 | 2006 |
Early versus late surgery for ileo‐caecal Crohn’s disease A Aratari, C Papi, G Leandro, A Viscido, L Capurso, R Caprilli Alimentary pharmacology & therapeutics 26 (10), 1303-1312, 2007 | 158 | 2007 |
Budesonide in the treatment of Crohn’s disease: a meta‐analysis C Papi, R Luchetti, L Gili, S Montanti, M Koch, L Capurso Alimentary pharmacology & therapeutics 14 (11), 1419-1428, 2000 | 156 | 2000 |
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor … A Orlando, A Armuzzi, C Papi, V Annese, S Ardizzone, L Biancone, ... Digestive and Liver Disease 43 (1), 1-20, 2011 | 154* | 2011 |
Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis?: A meta-analysis of randomized controlled trials A Moretti, C Papi, A Aratari, V Festa, M Tanga, M Koch, L Capurso Digestive and Liver Disease 40 (5), 379-385, 2008 | 152 | 2008 |
Crucial steps in the natural history of inflammatory bowel disease G Latella, C Papi World journal of gastroenterology: WJG 18 (29), 3790, 2012 | 139 | 2012 |
Infliximab in refractory pouchitis complicated by fistulae following ileo‐anal pouch for ulcerative colitis A Viscido, FI Habib, A Kohn, C Papi, A Marcheggiano, MT Pimpo, ... Alimentary pharmacology & therapeutics 17 (10), 1263-1271, 2003 | 114 | 2003 |
Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial R Caprilli, M Cottone, F Tonelli, G Sturniolo, F Castiglione, V Annese, ... Alimentary pharmacology & therapeutics 17 (4), 517-523, 2003 | 112 | 2003 |
Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis G Riegler, MT Tartaglione, R Carratu, R D'incá, D Valpiani, MI Russo, ... Digestive diseases and sciences 45, 462-465, 2000 | 111 | 2000 |
Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. C Papi, A Ciaco, M Koch, L Capurso The Italian journal of gastroenterology 24 (8), 452-456, 1992 | 102 | 1992 |
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study A Orlando, E Colombo, A Kohn, L Biancone, F Rizzello, A Viscido, ... Digestive and liver disease 37 (8), 577-583, 2005 | 101 | 2005 |
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian multicentre study L Cantoro, A Di Sabatino, C Papi, G Margagnoni, S Ardizzone, P Giuffrida, ... Journal of Crohn's and Colitis 11 (8), 975-980, 2017 | 91 | 2017 |
Adalimumab in active ulcerative colitis: a “real-life” observational study A Armuzzi, L Biancone, M Daperno, A Coli, D Pugliese, V Annese, ... Digestive and Liver Disease 45 (9), 738-743, 2013 | 88 | 2013 |